Advertisement
U.S. markets closed

Acme United Corporation (ACU)

NYSE American - NYSE American Delayed Price. Currency in USD
42.50-1.99 (-4.47%)
At close: 04:00PM EDT
42.58 +0.08 (+0.19%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close44.49
Open44.08
Bid42.38 x 1100
Ask42.59 x 1100
Day's Range41.68 - 44.08
52 Week Range23.24 - 50.99
Volume22,111
Avg. Volume25,159
Market Cap154.921M
Beta (5Y Monthly)0.70
PE Ratio (TTM)8.74
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.60 (1.41%)
Ex-Dividend DateMar 27, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ACU

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acme
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • GlobeNewswire

    Acme United to Release First Quarter 2024 Financial Results on April 19, 2024

    SHELTON, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for First Quarter 2024 on Friday, April 19, 2024, at 9:00 a.m. Eastern Time. A conference call to discuss these results will be broadcast over the internet on Friday, April 19, 2024, at 12:00 p.m. Eastern Time. To listen to or participate in a question-and-answer session, dial 1-877-407-0784, international callers dial 1-201-689-8560, conference ID: 13745527. Access

  • Newsfile

    Acme United Corporation to Present at The LD Micro Invitational XIV

    Presentation on Tuesday, April 9 at 3:00 PM ET Shelton, Connecticut--(Newsfile Corp. - March 26, 2024) - Acme United Corporation (NYSE American: ACU) announced today that it will present at the 14th Annual LD Micro Invitational, to be held at the Sofitel New York on April 8-9, 2024. Walter C. Johnsen, Chairman and CEO, will present on Tuesday, April 9, at 3:00 PM ET. Register to watch the virtual presentation here. A slide presentation ...

  • GlobeNewswire

    Acme United Corporation Board Approves Cash Dividend

    SHELTON, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 15 cents per share on its outstanding common stock. The dividend is payable on April 19, 2024, to stockholders of record on the close of business on March 28, 2024. ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial market